Sigyn Therapeutics Inc's Comment on Sales, Marketing and Customers
Sigyn Therapeutics, Inc. develops medical devices for the treatment of cancer and infectious disease disorders, with a focus on extracorporeal blood purification. Its therapeutic candidates include ImmunePrep™ to enhance immunotherapeutic antibodies, ChemoPrep™ to improve chemotherapy delivery, and ChemoPure™ to reduce chemotherapy toxicity. The company's lead candidate, Sigyn Therapy™, targets infectious disease disorders that are not treatable with drugs by extracting pathogens and toxins from the blood and modulating immune responses. Sigyn Therapy™ is intended to address unmet needs in global health, including untreatable viral pathogens, antibiotic-resistant bacterial infections, endotoxemia, and sepsis, a leading cause of hospital deaths in the United States. These therapies have potential applications in the pharmaceutical, dialysis, and organ transplant industries.
Sigyn Therapeutics Inc’s Comment on Sales, Marketing and Customers
Sigyn Therapeutics, Inc. develops medical devices for the treatment of cancer and infectious disease disorders, with a focus on extracorporeal blood purification. Its therapeutic candidates include ImmunePrep™ to enhance immunotherapeutic antibodies, ChemoPrep™ to improve chemotherapy delivery, and ChemoPure™ to reduce chemotherapy toxicity. The company's lead candidate, Sigyn Therapy™, targets infectious disease disorders that are not treatable with drugs by extracting pathogens and toxins from the blood and modulating immune responses. Sigyn Therapy™ is intended to address unmet needs in global health, including untreatable viral pathogens, antibiotic-resistant bacterial infections, endotoxemia, and sepsis, a leading cause of hospital deaths in the United States. These therapies have potential applications in the pharmaceutical, dialysis, and organ transplant industries.
Sources:
Sigyn Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sigyn Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sigyn Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
